Editas Medicine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
EDIT Key Statistics
Stock Snapshot
With a market cap of 266.01M, Editas Medicine(EDIT) trades at $2.73. The stock has a price-to-earnings ratio of -1.12.
As of 2025-11-12, Editas Medicine(EDIT) stock has fluctuated between $2.65 and $2.80. The current price stands at $2.73, placing the stock +2.8% above today's low and -2.7% off the high.
The Editas Medicine(EDIT)'s current trading volume is 1.62M, compared to an average daily volume of 2.42M.
During the past year, Editas Medicine(EDIT) stock moved between $0.91 at its lowest and $4.54 at its peak.
During the past year, Editas Medicine(EDIT) stock moved between $0.91 at its lowest and $4.54 at its peak.
EDIT News
Editas Medicine Inc. ( (EDIT) ) has released its Q3 earnings. Here is a breakdown of the information Editas Medicine Inc. presented to its investors. Meet Your...
Clear Street raised the firm’s price target on Editas Medicine (EDIT) to $4.60 from $4 and keeps a Buy rating on the shares following the Q3 report. The company...
Editas Medicine (EDIT) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.7...
